Haloperidol for treatment of cannabinoid hyperemesis syndrome

Am J Emerg Med. 2013 Jun;31(6):1003.e5-6. doi: 10.1016/j.ajem.2013.02.021. Epub 2013 Apr 10.

Abstract

Cannabinoid hyperemesis syndrome (CHS) is a condition characterized by cyclical vomiting without other identifiable cause in patients with chronic cannabis use. Patients with CHS report that compulsive bathing and hot showers are the only reliable treatments to improve symptoms. Cannabinoid hyperemesis syndrome is usually unresponsive to conventional pharmacologic antiemetics, and patients often require hospital admission. We report a case of CHS that improved significantly after treatment with haloperidol in the emergency department.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / chemically induced
  • Abdominal Pain / drug therapy
  • Adult
  • Antiemetics / therapeutic use*
  • Cannabinoids / adverse effects
  • Haloperidol / therapeutic use*
  • Humans
  • Male
  • Marijuana Abuse / complications*
  • Nausea / chemically induced
  • Nausea / drug therapy
  • Syndrome
  • Vomiting / chemically induced*
  • Vomiting / drug therapy

Substances

  • Antiemetics
  • Cannabinoids
  • Haloperidol